Attendees:
JJ Harkema (Experian);
Scott Shorter (IAWG Vice-Chair);
Matt King (SAFE-BioPharma);
David Simonetti (SAFE- BioPharma);
Richard Wilsher (Zygma);
Matt Williams (Exostar);
Colin Wallis ; Ruth Puenteand Ruth Puente (KI)
Agenda:
1. Welcome and Roll Call
2. Internet2 Update
3. Kantara Identity Assurance Working Group Update
4. SAFE-Biopharma Update
5. NIST and FICAM Updates
6. Open Mic
Incommon/Internet 2 Report
...
IAWG Report
SAFE - Biopharma
...
Bio-Pharma Update
- No further news from NIST.
- They also noted that the "authoritative sources" requirement is a challenge.
- They have seen interest from companies to be certified against 800-63-3. There seem to be a requirement from the Insurance, Banking and Healthcare industries on 63-3 compliance.
- Regarding AL2 minus, there have seen interest on something in between AL1 and AL2.
NIST SP 800-63-3
- Scott Shorter provided the link to NIST FAQ: https://pages.nist.gov/800-63-FAQ/
- Exostar commented that as they do not have a regulatory requirement or use case . they still do not have a specific strategy towards 63-3.